Results 101 to 110 of about 14,124,398 (277)

Reserves, Injury Severity, and Outcomes in Traumatic Brain Injury: A CENTER‐TBI Observational Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Reserve refers to the brain's ability to maintain function after an injury and strongly relates to traumatic brain injury (TBI) outcomes. This study examined (1) whether associations between pre‐injury reserve proxies and outcomes differed across injury severity categories, and (2) whether the impact of injury severity varied across ...
Natascha Ekdahl   +6 more
wiley   +1 more source

Drug-related problems identified in post-discharge medication reviews for patients taking warfarin

open access: yes, 2011
Objective: To characterise the nature of the drug-related problems with warfarin therapy identified in pharmacist-conducted medication reviews during a collaborative post-discharge warfarin management service, with a focus on potentially serious drug ...
Gregory Peterson   +11 more
core   +3 more sources

Current practice and determinants of medication management in long-term care facilities

open access: yesArchives of Pharmacy Practice, 2016
Background: Medication management is a complex process which involves different phases including prescribing, transcribing, ordering, dispensing, supplying, administering, and storing.
Chong Tze Wei, Marhanis Salihah Omar
doaj   +1 more source

Medication-related criteria in frailty assessment tools: A narrative review

open access: yes, 2020
Medication-related criteria in frailty assessment tools: A narrative ...
ME Dearing (15817019)   +4 more
core  

Modeling Progressive Brain Volume Losses in Chronic Moderate Severe Traumatic Brain Injury: Extensive, but Attenuating

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Progressive brain atrophy has now been widely observed in the chronic stages of moderate–severe traumatic brain injury (msTBI), but there is only coarse information regarding its prevalence and magnitude, and whether rate of atrophy accelerates or attenuates across time. We examined these questions in a Canadian inception cohort from
Robin E. A. Green   +6 more
wiley   +1 more source

Drug-related problems and changes in drug utilization after medication reviews in nursing homes in Oslo, Norway

open access: yesScandinavian Journal of Primary Health Care, 2017
Objective: We describe the drug-related problems (DRPs) identified during medication reviews (MRs) and the changes in drug utilization after MRs at nursing homes in Oslo, Norway. We explored predictors for the observed changes.
Amura Francesca Fog   +3 more
doaj   +1 more source

Systemic Extracerebral Atherosclerotic Burden and Dementia Risk After Incident Stroke

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Stroke survivors are at increased risk of dementia, but clinically accessible markers of risk heterogeneity remain limited. Previous studies have largely examined atherosclerotic disease in individual vascular beds rather than the overall burden of systemic extracerebral atherosclerosis.
Zhexuan Yu   +4 more
wiley   +1 more source

The development and evaluation of a medication diary to report problems with medication use

open access: yesHeliyon
Purpose: The study aimed to develop and evaluate a medication diary for patients to report problems with medication use to enable shared-decision making and improve medication adherence.
Laura Mortelmans, Tinne Dilles
doaj   +1 more source

Mapping the prevalence and nature of drug related problems among hospitalised children in the United Kingdom: a systematic review

open access: yesBMC Pediatrics, 2019
Background Problems arising from medicines usage are recognised as a key patient safety issue. Children are a particular concern, given that they are more likely than adults to experience medication-related harm.
Adam Sutherland   +3 more
doaj   +1 more source

Response to: "Consistent terminology for medication-related problems in pharmacogenomic cases". [PDF]

open access: yesJ Psychiatry Neurosci, 2023
Korchia T   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy